431 research outputs found

    Portraits and the Artist: Richard Rothwell’s Roman Adventures

    Get PDF
    Richard Rothwell was an Irish portraitist who was successful in Londonin the late 1820s. Despite this achievement he felt he had to leave Londonto acquaint himself with the Italian Masters and see what trends were indemand in Rome in the early 1830s. This chapter analyses how the Italianexperience affected his creativity and examines the reasons for his proclivitytowards genre and landscape over portraits in works produced up tohis death in 1868. Attention is paid to the Rothwell holdings in the NationalGallery of Ireland and the National Museum of Northern Ireland.The reasons for the negative reaction to Rothwell’s “Italian” art on his returnto England are examined while it is also argued that he may haveretained his initial success as a portrait painter had he never gone to Italy

    Abandoning ‘a Lifetime of Habits’ to Avoid the ‘Sins of the Past’: De-Congregating Institutions with Deeply Ingrained Traditions

    Get PDF
    While many studies have identified the problem of reproducing small institutions in community settings, few have explored why. This article explores how staff preserve and defend institutionalised beliefs and practices in community settings. We apply the concepts of disruptive and defensive institutional work to analyse the findings of qualitative interviews at six Irish residential institutions that were identified as priority sites for a national de-congregation programme. Reflecting on their roles, staff conceptualised their practices as historical, traditional, and reflective of a bygone era. However, the findings indicate that it would be misleading to represent institutional practices as relics of the past. The programme offered an olive branch for staff members who wanted to distance themselves from a ‘lifetime of habits’ and ‘sins of the past’

    Effect of acute citalopram on self-referential emotional processing and social cognition in healthy volunteers

    Get PDF
    This study was funded by the UK National Productivity Investment Fund awarded to C.H. through the GW4 BioMed Medical Research Council Doctoral Training Partnership. This study was supported by the National Institute for Health Research (NIHR) Oxford Health Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR or the Department of Health. ICMJE forms are in the supplementary material, available online at https://doi.org/10.1192/bjo.2020.107.Peer reviewedPublisher PD

    Cellular Therapies in Chronic Lymphocytic Leukemia and Richter’s Transformation: Recent Developments in Chimeric Antigen Receptor T-Cells, Natural Killer Cells, and Allogeneic Stem Cell Transplant

    Get PDF
    Cellular therapies can be viewed as both the newest and oldest techniques for treating chronic lymphocytic leukemia (CLL) and Richter’s transformation (RT). On one hand, allogeneic hematopoietic stem cell transplantation (alloHSCT) has been available for decades, though its use is diminishing with the increasing availability of effective novel targeted agents, especially in CLL. Among newer techniques, chimeric antigen receptor T-cells (CAR-T) have demonstrated astounding efficacy in several hematologic malignancies, leading to FDA approval and use in clinical practice. However, though CLL is the earliest disease type for which CAR-T were studied, development has been slower and has yet to lead to regulatory approval. Owing partially to its rarity but also due to the aggressive behavior of RT, CAR-T in RT have only been minimally explored. Here, we will focus on the applications of cellular therapies in CLL and RT, specifically reviewing more recent data related to alloHSCT in the novel-agent era and CAR-T cell development in CLL/RT, focusing on safety and efficacy successes and limitations. We will review strategies to improve upon CAR-T efficacy and discuss ongoing trials utilizing CAR-T in CLL/RT, as well as emerging technologies, such as allogeneic CAR-T and natural killer CAR (CAR NK) cells
    • …
    corecore